0002107396-26-000003.txt : 20260324 0002107396-26-000003.hdr.sgml : 20260324 20260324120648 ACCESSION NUMBER: 0002107396-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260324 DATE AS OF CHANGE: 20260324 EFFECTIVENESS DATE: 20260324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gilgamesh Pharma Inc. CENTRAL INDEX KEY: 0002107396 ORGANIZATION NAME: EIN: 393989868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-577482 FILM NUMBER: 26784903 BUSINESS ADDRESS: STREET 1: 113 UNIVERSITY PLACE, SUITE 1019 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 929-723-4861 MAIL ADDRESS: STREET 1: 113 UNIVERSITY PLACE, SUITE 1019 CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0002107396 Gilgamesh Pharma Inc. 113 UNIVERSITY PLACE, SUITE 1019 NEW YORK NY NEW YORK 10003 929-723-4861 DELAWARE None None Corporation true 2025 Jonathan Sporn 113 University Place, Suite 1019 New York NY NEW YORK 10003 Executive Officer Director Andrew Kruegel 113 University Place, Suite 1019 New York NY NEW YORK 10003 Executive Officer Director Zia Huque 113 University Place, Suite 1019 New York NY NEW YORK 10003 Director Amy Kruse 113 University Place, Suite 1019 New York NY NEW YORK 10003 Director Robert Berman 113 University Place, Suite 1019 New York NY NEW YORK 10003 Director Phil Skolnick 113 University Place, Suite 1019 New York NY NEW YORK 10003 Director Pharmaceuticals Decline to Disclose 06b false 2026-03-09 false true true Shares of Preferred Stock of Issuer and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert. false 50000 60000000 60000000 0 false 40 0 0 0 false Gilgamesh Pharma Inc. Jonathan Sporn /s/ Jonathan Sporn Chief Executive Officer 2026-03-24